DC47701 |
c-Myc inhibitor 4
|
c-Myc inhibitor 4 is a potent, orally bioavailable c-MYC-reducing compound. |
DC45837 |
MYC-IN-2
|
MYC-IN-2 is a MYC protein-protein inhibitor. MYC-IN-2 can be used for the research of cancer. |
DC45348 |
NY2267
|
NY2267 is a disruptor of Myc-Max interaction, with an IC50 of 36.5 μM. |
DC40285 |
Lusianthridin
|
Lusianthridin, a pure compound from Dendrobium venustum, have an anti-migratory effect. Lusianthridin enhances c-Myc degradation through the inhibition of Src-STAT3 signaling. |
DC11684 |
sAJM-589
|
sAJM-589 is a novel, potent small molecule Myc inhibitor that disrupts the Myc-Max leucine-zipper heterodimer with IC50 of 1.8 uM. |
DC11918 |
CMLD010509
|
A rocaglate (flavagline) derivative that acts a highly specific inhibitor of the oncogenic translation program supporting MM, including key oncoproteins such as MYC, MDM2, CCND1, MAF, and MCL-1. |